We observed low or silenced expression of FGF14 in both CRC tumor tissues and cell lines, accompanying promoter methylation of FGF14, suggesting that promoter methylation might be the predominant mechanism for the inactivation of FGF14 in CRC. The gene discussed is FGF14; the disease is neoplasm.